{"id":"W3010907432","doi":"10.1200/jco.2013.31.15_suppl.518","title":"A phase Ib study of an anti-HER2 inhibitor, lapatinib, in combination with a c-MET and VEGFR inhibitor, foretinib, in HER2-positive metastatic breast cancer (MBC): Results from NCIC CTG IND.198.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Cancer Care South East; McGill University; Royal Victoria Hospital; Queen's University; Cancer Care Ontario; Interior Health; BC Cancer Agency","funders":"","keywords":"Lapatinib; Medicine; Internal medicine; Metastatic breast cancer; Tyrosine-kinase inhibitor; Oncology; Pharmacokinetics; Phases of clinical research; Regimen; Breast cancer; Response Evaluation Criteria in Solid Tumors; Cancer; Pharmacology; Gastroenterology; Toxicity; Trastuzumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001380725,0.001639204,0.001709478,0.0005839755,0.0005847892,0.0009949906,0.001269766,0.001421547,0.003758258],"category_scores_gemma":[0.0009019356,0.0008751979,0.00107359,0.0005810795,0.001037245,0.0009170644,0.000368519,0.003358477,0.0008396659],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001052102,"about_ca_system_score_gemma":0.001993127,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001743869,"about_ca_topic_score_gemma":0.00356768,"domain_scores_codex":[0.9995427,0.0002178611,0.00002307384,0.00006958235,0.00004513449,0.0001016119],"domain_scores_gemma":[0.9991239,0.000152608,0.0001392142,0.00007133077,0.00005315468,0.0004598634],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5696777,0.2421532,0.008056464,0.001124572,0.001134914,0.0007627255,0.0005518801,0.00375545,0.08809324,0.0003497908,0.004883855,0.07945615],"study_design_scores_gemma":[0.3071429,0.6724972,0.009917256,0.00004125404,0.000342092,0.000488624,0.00007965745,0.0008355282,0.006118109,0.0001370793,0.002372097,0.00002811613],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9928417,0.001232104,0.0004997735,0.0003755841,0.00008423212,0.002525513,0.0009504053,0.00006289387,0.001427753],"genre_scores_gemma":[0.9865826,0.002025789,0.001659899,0.0007248131,0.0001531166,0.003306945,0.00246558,0.00004110735,0.003040044],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003758258,"threshold_uncertainty_score":0.01257259,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1020588886896414,"score_gpt":0.4980479330769425,"score_spread":0.3959890443873011,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}